Fibrinolysis inhibitors

Fibrinolysis inhibitors inhibit fibrinolysis by competitive inhibition of the plasminogen-activating enzyme and inhibition of plasmin formation (aminocaproic acid, aminomethylbenzoic acid, etc.) or by complexing with plasmin (aprotinin). Regardless of the mechanism of inhibition of fibrinolysis, they have a specific hemostatic effect in various pathological conditions in which the fibrinolytic activity of blood and tissues is…

Read More Fibrinolysis inhibitors